Cargando…
Analysis of the Delta Variant B.1.617.2 COVID-19
With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544471/ https://www.ncbi.nlm.nih.gov/pubmed/34698149 http://dx.doi.org/10.3390/clinpract11040093 |
_version_ | 1784589824733216768 |
---|---|
author | Shiehzadegan, Shayan Alaghemand, Nazanin Fox, Michael Venketaraman, Vishwanath |
author_facet | Shiehzadegan, Shayan Alaghemand, Nazanin Fox, Michael Venketaraman, Vishwanath |
author_sort | Shiehzadegan, Shayan |
collection | PubMed |
description | With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant has quickly become the dominant strain. Despite countries like the US, where most of the population is vaccinated, COVID-19 has made a resurgence in infections. Collectively, as a country, we ask: is it more deadly? What makes it more “contagious” or “transmissible”? This review article delves into the information we already know about the delta variant and how it compares with the other SARS-CoV-2 variants. The current vaccine companies like AstraZeneca, Pfizer/BioNTech, and Moderna have reported that their vaccines can provide protection against this variant but with a slightly reduced efficacy. In this article, we do a comprehensive review and summary of the delta B.1.617.2 variant and what makes it more contagious. |
format | Online Article Text |
id | pubmed-8544471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85444712021-10-26 Analysis of the Delta Variant B.1.617.2 COVID-19 Shiehzadegan, Shayan Alaghemand, Nazanin Fox, Michael Venketaraman, Vishwanath Clin Pract Review With the delta variant of COVID-19, known as B.1.617.2, quickly ramping up infections around the world, we need to understand what makes this variant more contagious. One study has reported that the delta variant is 60% more transmissible than the alpha variant. As of August 2021, the delta variant has quickly become the dominant strain. Despite countries like the US, where most of the population is vaccinated, COVID-19 has made a resurgence in infections. Collectively, as a country, we ask: is it more deadly? What makes it more “contagious” or “transmissible”? This review article delves into the information we already know about the delta variant and how it compares with the other SARS-CoV-2 variants. The current vaccine companies like AstraZeneca, Pfizer/BioNTech, and Moderna have reported that their vaccines can provide protection against this variant but with a slightly reduced efficacy. In this article, we do a comprehensive review and summary of the delta B.1.617.2 variant and what makes it more contagious. MDPI 2021-10-21 /pmc/articles/PMC8544471/ /pubmed/34698149 http://dx.doi.org/10.3390/clinpract11040093 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Shiehzadegan, Shayan Alaghemand, Nazanin Fox, Michael Venketaraman, Vishwanath Analysis of the Delta Variant B.1.617.2 COVID-19 |
title | Analysis of the Delta Variant B.1.617.2 COVID-19 |
title_full | Analysis of the Delta Variant B.1.617.2 COVID-19 |
title_fullStr | Analysis of the Delta Variant B.1.617.2 COVID-19 |
title_full_unstemmed | Analysis of the Delta Variant B.1.617.2 COVID-19 |
title_short | Analysis of the Delta Variant B.1.617.2 COVID-19 |
title_sort | analysis of the delta variant b.1.617.2 covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544471/ https://www.ncbi.nlm.nih.gov/pubmed/34698149 http://dx.doi.org/10.3390/clinpract11040093 |
work_keys_str_mv | AT shiehzadeganshayan analysisofthedeltavariantb16172covid19 AT alaghemandnazanin analysisofthedeltavariantb16172covid19 AT foxmichael analysisofthedeltavariantb16172covid19 AT venketaramanvishwanath analysisofthedeltavariantb16172covid19 |